Home
>
National Drug Code (NDC)
>
Trexall
Trexall - 51285-367-01 - (methotrexate)
Drug Information of Trexall
| Product NDC: | 51285-367 |
| Proprietary Name: | Trexall |
| Non Proprietary Name: | methotrexate |
| Active Ingredient(s): | 7.5 mg/1 & nbsp; methotrexate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Trexall
| Product NDC: | 51285-367 |
| Labeler Name: | Teva Women's Health, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA040385 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20010503 |
Package Information of Trexall
| Package NDC: | 51285-367-01 |
| Package Description: | 30 TABLET, FILM COATED in 1 BOTTLE (51285-367-01) |
NDC Information of Trexall
| NDC Code | 51285-367-01 |
| Proprietary Name | Trexall |
| Package Description | 30 TABLET, FILM COATED in 1 BOTTLE (51285-367-01) |
| Product NDC | 51285-367 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | methotrexate |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20010503 |
| Marketing Category Name | ANDA |
| Labeler Name | Teva Women's Health, Inc. |
| Substance Name | METHOTREXATE SODIUM |
| Strength Number | 7.5 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Folate Analog Metabolic Inhibitor [EPC],Folic Acid Metabolism Inhibitors [MoA] |
